NovoCure Ltd — Director's Dealing 2019

Nov 13, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2019-11-11

Reporting Person: DOYLE WILLIAM F (Director, Executive Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-11	Ordinary Shares	S	29782	$80.108	Disposed	822683	Direct
2019-11-12	Ordinary Shares	S	11118	$81.59	Disposed	811565	Direct
2019-11-12	Ordinary Shares	S	2100	$82.142	Disposed	809465	Direct

Footnotes

F1: On November 11, 2019, Mr. Doyle sold 29,782 shares in multiple trades at prices ranging from $80.00 to $80.45. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.

F2: On November 12, 2019, Mr. Doyle sold 11,118 shares in multiple trades at prices ranging from $81.07 to $82.07. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.

F3: On November 12, 2019, Mr. Doyle sold 2,100 shares in multiple trades at prices ranging from $82.08 to $82.24. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.